Egis Pharmaceuticals PLC

Egis Pharmaceuticals PLC is a Manufacturer/Innovator company operating in the pharmaceutical industry.

Egis Pharmaceuticals PLC is a leading generic pharmaceutical company operating principally in Central and Eastern Europe. The company’s activities incorporate all areas of the pharmaceutical value chain from R&D through production of APIs and finished products to sales and marketing in more than 60 countries. Egis has extensive experience in development of value-added generic molecules, efficient manufacturing processes, robust analytical methods for determination of impurities, comprehensive knowledge of organic chemical reactions and operations and strong IP support.

Company type

Manufacturer/Innovator

Products and services

Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)

Markets

North America (USA, Canada), Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address

Egis Pharmaceuticals PLC, Kereszturi ut 30-38, Budapest, Hungary, H-1106